Angela Lipscomb-Hudson, MD
Titles
Assistant Professor of Physical Medicine & Rehabilitation
Medical Director, Stroke Rehabilitation, UNC Rehabilitation Center
Director of Medical Student Education, PM&R
Education
Medical School: Howard University College of Medicine, 2007
Residency: Rehabilitation Institute of Chicago/Northwestern University Feinberg School of Medicine, 2008-2011
Preliminary Internal Medicine Internship: Carolinas Medical Center, 2007-2008
Certifications
American Board of Physical Medicine and Rehabilitation
Sub-Specialties
• Stroke Rehabilitation
• Obesity and Weight Management
• Parkinson’s Disease and Movement Disorders Rehabilitation
• Multiple Sclerosis Rehabilitation
• Traumatic Brain Injuries
• Neurological Rehabilitation
• Spasticity Management
• Botulinum Toxin Injections
• Peripheral Joint Injections
Honors
2012 UNC PM&R Teaching Excellence Award
2012 UNC PM&R Educational Module of the Year
2011 Rehabilitation Institute of Chicago Baskin’s Award for Excellence in Research, Resident Research Day
1st Place Award
2011 Rehabilitation Institute of Chicago (RIC) Dr. Scholl Award for Rehabilitation Research
2010 RIC/ Northwestern University Sewell Resident Award for Recognition of Achievement and Greatest
Potential in a Career in Academics or Research
Publications and Presentations
Kim K, Lipscomb A. Case of a C8-T1 Level Spinal Cord Injury Patient with Diaphragm Paralysis due to Bilateral Phrenic Nerve Injuries. Association of Academic Physiatrist Annual Meeting Scientific Presentations. Am J PMR. April 2010; 89 (4).
"Open Arms: Raising Awareness of Upper Limb Spasticity" with Henry Winkler. Presenter and panel member. May 22, 2012.
"The Obesity Epidemic: Physiatric Interventions of Select Comorbidities and Complications." UNC PM&R, January 2011.
Research Activity
A Phase III, Multicenter, Double Blind, Prospective, Randomized, Placebo Controlled Study Assessing the Efficacy and Safety of Dysport® Used for the Treatment of Lower Limb Spasticity in Adult Subjects with Hemiparesis Due To Stroke or Traumatic Brain Injury
Industry Sponsor: Ipsen
Role: Co-Investigator
6/2011-3/2013
A Phase III, Multicenter, Open Label, Extension Study, To Assess the Long Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects with Hemiparesis Due To Stroke or Traumatic Brain Injury
Industry Sponsor: Ipsen
Role: Co-Investigator
9/2011-6/2013
A Phase III, Multicenter, Double Blind, Prospective, Randomized, Placebo Controlled Study Assessing the Efficacy and Safety of Dysport® Intramuscular Injection Used for the Treatment of Upper Limb Spasticity in Adult Subjects with Hemiparesis Due To Stroke or Traumatic Brain Injury
Industry Sponsor: Ipsen
Role: Co-Investigator
Dates: 8/2011-6/2013
A Phase III, Multicenter, Open Label, Extension Study, To Assess the Long Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Upper Limb Spasticity in Adult Subjects with Hemiparesis Due To Stroke or Traumatic Brain Injury
Industry Sponsor: Ipsen
Role: Co-Investigator
Dates: 11/2011-9/2013
Professional Memberships
Association of Academic Physiatrists
American Academy of Physical Medicine and Rehabilitation
American Congress of Rehabilitation Medicine
